DJIA 15,660.18 -254.56 -1.60%
NASDAQ 4,266.84 -16.76 -0.39%
S&P 500 1,829.08 -22.78 -1.23%
market minute promo

Biogen (NASDAQ: BIIB)

245.11 -7.09 (-2.81%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BIIB $245.11 -2.81%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $246.31
Previous Close $252.20
Daily Range $243.03 - $250.02
52-Week Range $243.03 - $480.18
Market Cap $54.6B
P/E Ratio 16.48
Dividend (Yield) $0.00 (0.0%)
Volume 2,170,856
Average Daily Volume 2,172,317
Current FY EPS $16.60

Sector

Healthcare

Industry

Drug Makers

Biogen (BIIB) Description

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website: http://www.biogenidec.com/

News & Commentary Rss Feed

Why Biogen Inc.'s Stock Sank in January

Biogen's slowing growth has investors looking towards the future.

See Which Of The Latest 13F Filers Holds Biogen

Gilead, Johnson & Johnson or Roche?

Massachusetts-Based Proteostatis Therapeutics IPO: Early Stage And Stiff Competition Keeps Us Cautio

Massachusetts-Based Proteostatis Therapeutics IPO: Early Stage And Stiff Competition Keeps Us Cautious

Jeff Auxier Takes Plunge in Fastenal, a Stock From Watchlist

Regeneron Disappoints, The Stock Sells Off: Analysis Of Its Growth Potential

Major Biotech Short Interest Continues to Be Mixed

Biotech ETFs Slide as Stocks Report Mixed Q4 Results

The Agony of High Returns

Even with a time machine, a lot of people wouldn't want to own the best-performing stocks.

Schoenebaum: Biotech P/Es Show 'Buying Signal' With Caveat; Amgen, Biogen, Celgene & Gilead Have Cat

Schoenebaum: Biotech P/Es Show 'Buying Signal' With Caveat; Amgen, Biogen, Celgene & Gilead Have Catalysts

See More BIIB News...

BIIB's Top Competitors

BIIB $245.11 (-2.81%)
Current stock: BIIB
AMGN $141.46 (-1.63%)
Current stock: AMGN
GILD $87.36 (-0.50%)
Current stock: GILD
CELG $99.59 (-3.46%)
Current stock: CELG